ctrl K

AI Score

Unlock

Keros Therapeutics Inc. (KROS)

AI Score

Unlock

11.09

0.08 (0.73%)

At close: Feb 28, 2025, 3:59 PM

11.00

-0.77%

After-hours: Feb 28, 2025, 06:27 PM EST

Keros Therapeutics Income Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	3.55M	151K	n/a	20.1M	n/a	10M	10M
Cost of Revenue	n/a	815K	1.61M	898K	605K	17.35M	10.11M
Gross Profit	3.55M	-664K	-1.61M	19.2M	-605K	-7.35M	-111K
Operating Income	-210.83M	-169.94M	-114.79M	-56.37M	-46.66M	-10.56M	-1.69M
Interest Income	n/a	n/a	1K	4K	6K	8K	6K
Pretax Income	-187.05M	-152.99M	-104.68M	-56.73M	-45.53M	-12.34M	-1.08M
Net Income	-187.35M	-152.99M	-104.68M	-58.74M	-45.36M	-12.34M	-1.33M
Selling & General & Admin	40.75M	34.83M	27.52M	21.33M	12.8M	3.18M	1.58M
Research & Development	173.63M	135.26M	87.27M	55.14M	33.86M	17.38M	10.11M
Other Expenses	n/a	n/a	-7.08M	-356K	-2.46M	-558K	237K
Operating Expenses	214.38M	170.09M	107.71M	76.47M	44.2M	20M	11.32M
Interest Expense	n/a	n/a	1K	4K	6K	8K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	214.38M	170.09M	107.71M	76.47M	44.2M	20M	11.32M
Income Tax	300K	n/a	1K	2.01M	-172K	8K	257K
Shares Outstanding (Basic)	37.44M	29.45M	25.24M	23.33M	15.51M	8.88M	8.88M
Shares Outstanding (Diluted)	37.44M	29.45M	25.24M	23.33M	15.51M	8.88M	8.88M
EPS (Basic)	-5	-5.2	-4.15	-2.52	-2.93	-1.39	-0.15
EPS (Diluted)	-5	-5.2	-4.15	-2.52	-2.93	-1.39	-0.15
EBITDA	-185.82M	-152.18M	-103.06M	-56.37M	-44.92M	-11.89M	-774K
Depreciation & Amortization	1.23M	815K	1.61M	898K	605K	438K	304K